Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-07

Clinical Trial Update: Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for KZ101 (suramin) in male pediatric patients with Autism Spectrum Disorder indicates the study is currently recruiting. The sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suramin (suramin)

Snippet

Sponsor: Children's Hospital of Orange County | Conditions: Autism Spectrum Disorder (ASD) | Phase 2 | Status: RECRUITING